Bone Biologics (BBLGW) Notes Payables (2016 - 2017)
Bone Biologics (BBLGW) has disclosed Notes Payables for 2 consecutive years, with $2.9 million as the latest value for Q3 2017.
- Quarterly Notes Payables changed N/A to $2.9 million in Q3 2017 from the year-ago period, while the trailing twelve-month figure was $2.9 million through Sep 2017, changed N/A year-over-year, with the annual reading at $1.2 million for FY2016, N/A changed from the prior year.
- Notes Payables for Q3 2017 was $2.9 million at Bone Biologics, up from $2.1 million in the prior quarter.
- The five-year high for Notes Payables was $2.9 million in Q3 2017, with the low at $1.2 million in Q4 2016.